Renephra is a medical device development company developing a ground breaking technology address the significant problems of fluid overload and chronic oedema in vascular, oncology and other disease areas. This is a substantial patient group with unmet clinical needs and is an estimated £3billion market worldwide.

The Renephra patented Fluid Removal Device uses micro-needle technology combined with negative pressure therapy to access and remove excess interstitial fluid from the skin, watch the video here

Recently Renephra achieved proof of concept in humans and is now engaged in a major equity fundraising to fund product development and design and clinical validation to regulatory approvals.